Prevalence of epilepsy in Morocco: A population-based study
Zouhayr Souirti1,2, Mohammed Hmidani1, Abdelaziz Lamkadddem1
1Clinical Neurosciences Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
Epilepsia Open
|October 7, 2023
Summary
This study provides the first estimates of epilepsy prevalence in Morocco, finding rates comparable to other low- and middle-income countries. These findings are crucial for developing national epilepsy action programs.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Epilepsy epidemiology data is lacking in Morocco.
- This data is essential for national epilepsy intervention programs.
Purpose of the Study:
- To estimate the active and lifetime prevalence of epilepsy in Morocco.
- To provide a basis for national epilepsy action plans.
Main Methods:
- A two-step approach was used across eight Moroccan regions.
- A nationwide telephone screening questionnaire was followed by physician-conducted confirmative surveys for suspected cases.
Main Results:
- The study confirmed 63 cases of lifetime epilepsy and 56 cases of active epilepsy.
- Lifetime epilepsy prevalence was 19.8 per 1000, and active epilepsy prevalence was 17.6 per 1000.
- The mean age of individuals with epilepsy was 35.53 years.
Conclusions:
- This is the first study to estimate epilepsy prevalence in Morocco per ILAE recommendations.
- Morocco's epilepsy prevalence rates align with those in Asian and sub-Saharan African low- and middle-income countries.
- The study included diverse age groups, from children to the elderly.
Related Concept Videos
01:24Arteries of the Lower Limbs
198
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
198
01:13Seizures: Classification
384
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
384
01:08Prevalence and Incidence
606
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
606
01:20Antiepileptic Drugs: Potassium Channel Activators
196
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
196